PRIMARY STUDY
Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials
Key Findings: Cannabinoids show promise as an effective treatment for chronic neuropathic pain, measured by significant improvements in sleep, pain scores, and patients' global impression of change (PGIC) in this meta-analysis and systematic review.
Type of Study: Clinical Meta-analysis
Study Sample Size: 8
Study Result: Positive
Research Location(s): Canada
Year of Pub: 2022
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Citation: McParland AL, et al. Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. Reg Anesth Pain Med. 2023; 48:180-190. doi: 10.1136/rapm-2021-103431
Authors: McParland AL, Bhatia A, Matelski J, Tian C, Diep C, Clarke H, Kapustin D, Triveda A, Brull R, Singh M
